Get started
Author

Oluwaseyi Oluwatola

Observed names: Oluwaseyi E Oluwatola, Oluwaseyi E. Oluwatola
ORCID: 0000-0002-9527-6493
Observed ORCID: 0000-0002-9527-6493
OpenAlex ID: A5020775443
Comprehensive assessment on the applications of oncolytic viruses for cancer immunotherapy
2022 · Richard Kolade Omole, Oluwaseyi Oluwatola, et al. · Frontiers in Pharmacology · 20
PDF
L-DOS47 Elevates Pancreatic Cancer Tumor pH and Enhances Response to Immunotherapy
2024 · Bruna Victorasso Jardim-Perassi, Pietro Irrera, et al. · Biomedicines · 11
PDF
Transdermal bicarbonate buffer therapy increases intratumoral pH and elicits antitumor responses in bladder cancer
2026 · Oluwaseyi Oluwatola, Sarah Bazargan, et al. · Frontiers in Immunology · 3
PDF
Tumor-associated KLRG1+ Tregs drive a dominant immunosuppressive program in Non-small Cell Lung Cancer
2024 · Oluwaseyi Oluwatola, Saheed Oseni, et al. · The Journal of Immunology · 2
853 Effect of transdermal bicarbonate buffer therapy on tumor acidity and CD8 T cell responses in bladder cancer
2024 · Oluwaseyi E Oluwatola, Pietro Irrera, et al. · Regular and Young Investigator Award Abstracts
The functional role of KLRG1+ Tregs in Non-small Cell Lung Cancer.
2024 · Oluwaseyi Oluwatola, Arup Bag, et al. · The Journal of Immunology
Abstract A080: The immunological signatures of African American prostate cancer as biological determinants of disease disparity
2023 · Saheed O. Oseni, Arup Bag, et al. · Cancer Epidemiology Biomarkers & Prevention
Works count: 7
Citation count: 36
H-index: 3
I10-index: 2
Year
Topic
Type